Improved survival in thalassemia major patients on switching from desferrioxamine to combined chelation therapy with desferrioxamine and deferiprone

Saved in:
Bibliographic Details
Published inHaematologica (Roma) Vol. 94; no. 12; pp. 1777 - 1778
Main Authors Telfer, Paul T, Warburton, Fiona, Christou, Soteroula, Hadjigavriel, Michael, Sitarou, Maria, Kolnagou, Anita, Angastiniotis, Michael
Format Journal Article
LanguageEnglish
Published Italy Ferrata Storti Foundation 01.12.2009
Subjects
Adult
beta-Thalassemia - blood
beta-Thalassemia - drug therapy
Chelation Therapy - methods
Deferoxamine - therapeutic use
Drug Therapy, Combination
Female
Humans
Iron
Iron Chelating Agents - therapeutic use
Letters to the Editor
Male
Middle Aged
Multivariate Analysis
Pyridones - therapeutic use
Siderophores - therapeutic use
Survival Analysis
Time Factors
Young Adult
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ObjectType-Commentary-2
ObjectType-Article-3
ISSN:0390-6078
1592-8721
DOI:10.3324/haematol.2009.009118